Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammation

Kim, Changyoun, Spencer, Brian, Rockenstein, Edward · Molecular Neurodegeneration · 2018